Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2025-12-25 @ 2:09 AM
NCT ID:
NCT01029860
Eligibility Criteria:
Inclusion Criteria:
* age \>30 years old.
* subject has signed an informed consent.
* patient has untreated ocular hypertension (IOP at 10:00 between 22-34 mm Hg)
* patient has stage 1 arterial hypertension with or without therapy
Exclusion Criteria:
* secondary hypertension.
* stage 2 or 3 hypertension, history of renal disease.
* sleep apnea.
* diabetes mellitus
* acute or chronic inflammation.
* myocardial infarction or unstable angina within the past 6 months.
* heart failure NYHA class III-IV.
* active liver disease.
* pregnancy.
* history of drug or alcohol abuse, or any other condition with poor prognosis.
* treatment with non-steroid anti-inflammatory agents, corticosteroids, beta-blockers, or any other regimen that could affect BP levels.
* smoking
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
65 Years
Study:
NCT01029860
Study Brief:
Protocol Section:
NCT01029860